These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38713010)

  • 21. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.
    Lind SE; Boyle ME; Fisher S; Ishimoto J; Trujillo TC; Kiser TH
    Am J Clin Pathol; 2014 May; 141(5):665-74. PubMed ID: 24713737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Bivalirudin Versus Heparin for Maintenance Systemic Anticoagulation During Adult and Pediatric Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Bohman JK; Schulte PJ; Hanson AC; Aganga DO
    Crit Care Med; 2021 Sep; 49(9):1481-1492. PubMed ID: 33870916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
    Van Cott EM; Roberts AJ; Dager WE
    Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
    Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
    J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation.
    Seelhammer TG; Brokmeier HM; Hamzah M; Wieruszewski PM
    Crit Care Med; 2023 May; 51(5):e115-e121. PubMed ID: 36853326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices.
    Pieri M; Agracheva N; Di Prima AL; Nisi T; De Bonis M; Isella F; Zangrillo A; Pappalardo F
    Artif Organs; 2014 Apr; 38(4):342-6. PubMed ID: 24102357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study.
    Puri K; Tunuguntla HP; Hensch LA; Loh J; Hui SK; Razavi A; Tume SC; Humlicek TJ; Denfield SW; Spinner JA; Choudhry S; Price JF; Dreyer WJ; Adachi I; Teruya J
    Pediatr Crit Care Med; 2022 Oct; 23(10):e465-e475. PubMed ID: 35687091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bivalirudin Anticoagulation for an Infant with Hyperbilirubinemia and Elevated Plasma-Free Hemoglobin on ECMO.
    Ezetendu C; Jarden A; Hamzah M; Stewart R
    J Extra Corpor Technol; 2019 Mar; 51(1):26-28. PubMed ID: 30936585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization and Outcomes of Children Treated with Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support.
    VanderPluym CJ; Cantor RS; Machado D; Boyle G; May L; Griffiths E; Niebler RA; Lorts A; Rossano J; Sutcliffe DL; Lytrivi ID; Buchholz H; Fynn-Thompson F; Hawkins B; Conway J
    ASAIO J; 2020 Aug; 66(8):939-945. PubMed ID: 32740356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
    Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
    J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
    Liveris A; Bello RA; Friedmann P; Duffy MA; Manwani D; Killinger JS; Rodriquez D; Weinstein S
    Pediatr Crit Care Med; 2014 Feb; 15(2):e72-9. PubMed ID: 24335992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation.
    Machado DS; Garvan C; Philip J; Harrington D; Spiess B; Kelly B; Campbell CT; Pelletier JPR; Islam S; Peek GJ; Bleiweis MS
    ASAIO J; 2021 Jun; 67(6):688-696. PubMed ID: 33031157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.
    Seelhammer TG; Rowse P; Yalamuri S
    J Cardiothorac Vasc Anesth; 2021 Apr; 35(4):1149-1153. PubMed ID: 32660924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support.
    Trigonis R; Smith N; Porter S; Anderson E; Jennings M; Kapoor R; Hage C; Moiz S; Garcia J; Rahman O
    J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):414-418. PubMed ID: 34782234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.
    Runyan CL; Cabral KP; Riker RR; Redding D; May T; Seder DB; Savic M; Hedlund J; Abramson S; Fraser GL
    Pharmacotherapy; 2011 Sep; 31(9):850-6. PubMed ID: 21923585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
    Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
    ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of bivalirudin in pediatric ventricular assist devices.
    Burstein D; Kimmel S; Putt M; Rossano J; VanderPluym C; Ankola A; Lorts A; Maeda K; O'Connor M; Edelson J; Lin K; Buchholz H; Conway J
    J Heart Lung Transplant; 2023 Mar; 42(3):390-397. PubMed ID: 36333207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review.
    Sanfilippo F; Asmussen S; Maybauer DM; Santonocito C; Fraser JF; Erdoes G; Maybauer MO
    J Intensive Care Med; 2017 Jun; 32(5):312-319. PubMed ID: 27356945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.